EHD2 anticorps (N-Term)
Aperçu rapide pour EHD2 anticorps (N-Term) (ABIN5516007)
Antigène
Voir toutes EHD2 AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Séquence
- SFIQYLLEQE VPGSRVGPEP TTDCFVAVMH GDTEGTVPGN ALVVDPDKPF
-
Purification
- Affinity purified
-
Immunogène
- The immunogen is a synthetic peptide directed towards the N terminal region of human EHD2
-
-
-
-
Indications d'application
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.
-
-
- EHD2 (EH-Domain Containing 2 (EHD2))
-
Autre désignation
- EHD2
-
Sujet
-
This gene encodes a member of the EH domain-containing protein family. These proteins are characterized by a C-terminal EF-hand domain, a nucleotide-binding consensus site at the N terminus and a bipartite nuclear localization signal. The encoded protein interacts with the actin cytoskeleton through an N-terminal domain and also binds to an EH domain-binding protein through the C-terminal EH domain. This interaction appears to connect clathrin-dependent endocytosis to actin, suggesting that this gene product participates in the endocytic pathway.
Alias Symbols: PAST2
Protein Size: 543 -
ID gène
- 30846
-
NCBI Accession
- NM_014601, NP_055416
-
UniProt
- Q9NZN4
-
Pathways
- Regulation of Muscle Cell Differentiation, Skeletal Muscle Fiber Development
Antigène
-